Bristol Myers Squibb Deploys Claude AI to 30,000+ Employees to Accelerate Drug Development

According to Guru Club, Bristol Myers Squibb began deploying Anthropic's Claude AI model to its 30,000+ employees on May 20 to accelerate drug discovery, development, and market launch. The company will also leverage Claude Code for programming tasks and evaluate its applications across research, drug development, manufacturing, and other business and medical operations.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments